Metformin

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

1,000 PubMed studies analyzed · 353 RCTs · Evidence Score: 71.9

Research Domains

Metformin has been studied across 16 research domains including 🔥 Metabolic, 🧬 Hormones, 🔬 Oncology, ❤️ Cardiovascular, ♀♂ Sexual Health. The primary research focus is 🔥 Metabolic with 88% of studies addressing this area.

Loading evidence profile...

This evidence profile for Metformin is generated deterministically from 1,000 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.